AI Agent Development Company in Melbourne

Regulatory classification does more to a Melbourne agent budget than model choice: a scoped Melbourne AI agent proof of concept (use-case shaping, AI Ethics Principles assessment, AI Assurance Framework risk classification, prototype orchestration, evaluation harness, hosted demo), a production customer-service or AML-triage agent inside an APRA-regulated bank (ANZ, NAB, Westpac scale), or full multi-agent systems with tool use across Genesys Cloud, Salesforce Service Cloud, ServiceNow, Workday, SAP, and a core banking platform. Scope drivers include orchestration, retrieval, evaluation, observability, monitoring, CPS 234 control mapping, ASIC RG 271 dispute resolution paths, and an APRA-grade model card. CSL-grade TGA-conformity-assessed agents sit at the upper end. Melbourne rates sit at the top of the ANZ band — bank, biotech, and ASX 50 head office work pulls a CPS 230 and TGA-aware talent premium. We give fixed-fee proposals rather than open T and M estimates.

APRA Prudential Standard CPS 230 Operational Risk Management took effect 1 July 2025 and consolidates obligations across operational risk, business continuity, and service provider management. For an AI agent inside an APRA-regulated entity (the Big Four banks, the major super funds, the major insurers), the agent counts as a critical operation if it supports a critical operation, and the underlying LLM vendor, hosting provider, vector store, and evaluation tool count as service providers under Section 4 of the standard. That means the agent ships with a documented critical operation register entry, tolerance levels for disruption, scenario analysis covering the LLM vendor going offline or a model deprecation, a service provider register entry for each external dependency, and an incident management runbook that fits the bank's existing CPS 230 framework. The developing CPS 250 on AI in financial services, which builds on the APRA AI guidance issued in 2024, adds further obligations on model risk management, explainability, and human oversight. Our discovery phase runs both screens on day one for any APRA-regulated client.

Yes. AML transaction monitoring, suspicious matter reporting, threshold transaction reporting, international funds transfer instruction reporting, and KYC document extraction are common agent use cases inside Melbourne banks, super funds, insurers, and remittance providers. The AUSTRAC AML/CTF Act 2006 imposes ongoing obligations on reporting entities — Chapter 4 covers customer identification and ongoing customer due diligence, Chapter 8 covers AML/CTF programs and risk-based systems and controls. Our agents ship with a documented AML/CTF Program mapping, lineage logging on every decision, human-in-the-loop review surfaces for suspicious matter triage, and integration with the bank's existing case management platform (Actimize, SAS AML, Quantexa, or FICO TONBELLER patterns). We build inside CPS 230 critical operation register expectations and CPS 234 information security controls, with full audit trail retention aligned to the seven-year AUSTRAC obligation. Final regulatory characterisation of any specific agent's role sits with the bank's AUSTRAC compliance officer.

CSL Behring at Parkville is one of the world's largest plasma collectors, runs the COMIRNATY and other vaccine manufacturing operations under the Therapeutic Goods Act 1989, and runs a global supply chain for Privigen, Hizentra, and other plasma therapies. AI agents inside CSL operations split into two regulatory buckets. Internal operational agents (supply-chain orchestration, document extraction, internal copilots) sit outside TGA software-as-a-medical-device classification but inside the TGA's broader Quality Management System and Good Manufacturing Practice expectations under PIC/S PE 009 and the Therapeutic Goods (Manufacturing Principles) Determination. Clinical or pharmacovigilance agents that influence a clinical decision can fall inside the 2021 TGA reforms on software-based medical devices and require ARTG inclusion, conformity assessment, and post-market surveillance. Our discovery phase runs a TGA classification screen on every CSL-style biotech agent, coordinates with the client's regulatory affairs team, and structures the agent inside whichever envelope applies. We do not pretend the regulatory work is easier than it is.

The Australian Government AI Ethics Principles, published by the Department of Industry, Science and Resources, set out eight principles: human, societal and environmental wellbeing; human-centred values; fairness; privacy protection and security; reliability and safety; transparency and explainability; contestability; accountability. The AI Assurance Framework, also under DISR, classifies AI systems by risk tier and sets expectations for assurance activities at each tier. For a customer-facing Melbourne AI agent, we run an AI Ethics Principles assessment in discovery, classify the agent against the AI Assurance Framework risk tiers (low, medium, high), document the training and retrieval data lineage with sensitive-attribute proxies identified, ship plain-language disclosures aligned to the Government Communications Style Manual where the agent is on a federally-funded surface, and build contestability paths so an end user can request human review under ASIC RG 271 or the relevant sector dispute resolution scheme. For NSW Government-adjacent agents we additionally align to the NSW AI Assurance Framework and the Algorithm Charter.

A typical Melbourne production agent (bank customer-service agent, AML triage agent, CSL supply-chain orchestration agent, Telstra billing-dispute copilot) takes eighteen to thirty-two weeks from kickoff to production, assuming clean retrieval data, a defined APRA CPS 230 or TGA Quality Management System control set, and a clear AI Ethics Principles risk classification from week one. Week 1 to 4 is use-case shaping, AI Ethics Principles assessment, and baseline orchestration. Week 5 to 14 is iteration, evaluation harness build-out, and tool-use integration. Week 15 to 22 is observability, monitoring, shadow mode deployment, CPS 234 control validation, and the APRA or TGA artefact pack. Week 23 onward is gradual rollout under a CPS 230 critical operation register entry or a TGA post-market surveillance plan. If the agent touches AUSTRAC AML decisions or TGA-classified clinical decisions, add eight to sixteen weeks for the regulatory artefacts. We have calibrated this timeline against APRA, AUSTRAC, and TGA expectations and against ANZ, NAB, Westpac, and CSL procurement patterns.

When a project genuinely needs novel research (novel agent architectures, advanced reasoning chains, advanced tool-use patterns, foundation model adaptation on rare domains, agentic reinforcement learning at production scale), we scope collaborations with the University of Melbourne (Group of Eight, top-ranked in Australia by QS), Monash University (Group of Eight, strong AI and biomedical research), RMIT University on Swanston Street (strong applied AI and industry partnership track record), Deakin University, and La Trobe University rather than overselling in-house capability. The University of Melbourne's School of Computing and Information Systems and the Centre for AI and Digital Ethics produce research directly relevant to APRA-regulated AI work. Our core team handles applied engineering, agent orchestration, MLOps, and productionisation, which is where most Melbourne agent projects actually stall. For standard work (LangGraph or CrewAI orchestration on well-known patterns, RAG, fine-tuning on standard open-weight models) no academic partner is needed. We will tell you up front which bucket your problem fits into.

Most custom AI agent work qualifies for the Australian Government Research and Development Tax Incentive (R&DTI). For Australian companies with aggregated turnover under AUD $20M the refundable offset is the corporate tax rate plus 18.5 percentage points (currently 43.5 percent total), and above $20M the non-refundable offset is a two-tier intensity premium of 8.5 or 16.5 percentage points above the company tax rate. Eligible core R&D activity generally includes novel agent architectures, advanced reasoning chains, evaluation methodology under algorithmic uncertainty, custom prompt-injection defence research, and systematic investigation against documented hypotheses; routine integration of OpenAI, Anthropic, or LangGraph patterns does not qualify on its own. Victorian companies can stack the Victorian Government's LaunchVic programmes, the Industry R&D Infrastructure Fund, and CRC Project grants where eligible. We deliver time-tracked logs, technical narratives, experiment histories, and failed-hypothesis documentation aligned with the AusIndustry R&D Tax Incentive registration form. Final eligibility sits with your registered R&D tax adviser and AusIndustry.